
"Sector" = median of Healthcare across 84 companies
Henry Schein, Inc. is a leading distributor of healthcare products and services, primarily serving dental and medical practitioners. Founded in 1932 and headquartered in Melville, New York, the company operates in the Medical Distribution industry within the Healthcare sector. With a market capitalization of $8.82 billion, Henry Schein provides a comprehensive range of products including dental supplies, equipment, pharmaceuticals, and practice management software. The company also offers value-added services such as inventory management, e-commerce solutions, and continuing education for healthcare professionals.
Henry Schein generates revenue through the distribution of branded and private-label products to dental and medical offices, laboratories, and other healthcare facilities. Its business model relies on a vast network of suppliers and efficient logistics to deliver over 120,000 stock-keeping units (SKUs). Revenue is primarily derived from product sales, with a smaller portion from services and technology solutions. The company's gross margin stands at 31.14%, while its operating margin is 5.75%, reflecting the competitive nature of distribution. Recent quarterly revenues have been around $3.3 billion, with net income averaging $100 million per quarter.
The medical distribution industry is highly competitive, with key players including McKesson, Cardinal Health, and Patterson Companies. Henry Schein differentiates itself through its strong focus on the dental segment, where it holds a leading market position. The company also benefits from scale, a broad product portfolio, and a global footprint. Its EV/EBITDA ratio of 12.80 suggests a moderate valuation relative to earnings. Despite a slight decline in earnings year-over-year (-2.73%), revenue growth of 6.31% indicates steady demand. The company's debt of $3.41 billion is manageable given its cash flow, with a free cash flow yield of 4.74%.
Henry Schein's primary customers are dental and medical professionals, including solo practitioners, group practices, and clinics. The company also serves hospitals, government agencies, and academic institutions. Geographically, the majority of revenue comes from North America, with a growing presence in Europe, Asia, and other international markets. The company's target audience values reliability, product breadth, and value-added services. By focusing on the needs of healthcare providers, Henry Schein has built a loyal customer base and a strong brand in the distribution industry.
An auto-generated descriptive profile based on company data, for informational purposes only.
No 24-hour summary has been generated yet.
Latest saved period: March 2026 · 2026-03-31
Cash dividends by ex-date, not an investment recommendation.
Wrqti brings Henry Schein, Inc. data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Companies in the Healthcare sector you can compare with Henry Schein, Inc.:
Compare Henry Schein, Inc. head-to-head with:
When available, the page shows quarterly and annual statements plus ratios such as PE, price to book, profit margin, and free cash flow. Latest financial period shown: March 2026.
Wrqti content depends on available data and third-party sources and may include delays or errors. Review official company filings and consult a licensed financial advisor before making investment decisions. Read the data methodology.